A2a Pharmaceuticals Inc.
Clinical trials sponsored by A2a Pharmaceuticals Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug AO-252 targets Hard-to-Treat cancers in early trial Results expected Jan 2027 (estimated)